FACTORS AFFECTİNG ENTERAL FEEDİNG INTOLERANCE İN INTENSİVE CARE UNİT PATİENTS
EFI-ICU
1 other identifier
observational
102
0 countries
N/A
Brief Summary
Enteral nutrition is the first-line nutritional support method in critically ill patients because it helps preserve gastrointestinal system integrity, reduce the risk of infection, and meet metabolic requirements. However, gastrointestinal motility is frequently impaired in critically ill patients due to physiological stress, hemodynamic instability, sedative and vasopressor medications, mechanical ventilation, and underlying diseases. This may result in enteral feeding intolerance (EFI), which complicates nutritional management. This prospective observational study aims to determine the demographic, clinical, laboratory, and treatment-related factors associated with enteral feeding intolerance in adult intensive care unit patients and to evaluate the association between enteral feeding intolerance and morbidity and mortality. Adult patients who are started on enteral nutrition in the Anesthesiology and Reanimation Intensive Care Unit will be prospectively followed. No additional intervention will be performed. Patients will be monitored according to routine intensive care and enteral nutrition protocols. Enteral feeding intolerance and potentially associated factors will be recorded prospectively. The study is planned to include 102 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
August 21, 2026
August 1, 2026
1 month
August 12, 2026
August 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of Enteral Feeding Intolerance
Enteral feeding intolerance will be defined by the presence of at least one predefined clinical criterion: vomiting, a single gastric residual volume greater than 250 mL, 24-hour cumulative gastric residual volume greater than 500 mL, abdominal distension, or clinical suspicion of aspiration related to enteral feeding.
7 days
Secondary Outcomes (1)
Achievement of Energy Target
3 days
Eligibility Criteria
The study population will consist of adult patients aged 18 years or older who are admitted to the Anesthesiology and Reanimation Intensive Care Unit of Ankara Atatürk Sanatoryum Training and Research Hospital and who are started on enteral nutrition. Patients will be prospectively screened and consecutively enrolled if they meet all inclusion criteria and none of the exclusion criteria.
You may qualify if:
- Age ≥18 years
- Admission to the Anesthesia Intensive Care Unit
- Enteral nutrition planned or initiated during intensive care unit admission
- Expected to require enteral nutrition during intensive care unit follow-up
- Availability of sufficient clinical and nutritional data for study evaluation
- Patient or legally authorized representative provides informed consent when required by the ethics protocol
You may not qualify if:
- Age \<18 years
- Patients receiving only parenteral nutrition
- Patients in whom enteral nutrition is contraindicated throughout the observation period
- Patients with insufficient data for evaluation of enteral feeding tolerance
- Patients transferred to another intensive care unit before adequate study assessment
- Patients who decline participation or whose legally authorized representative declines participation when consent is required
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 21, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
August 21, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share